Ali Murtadha Al Lawati has been appointed Chairman of the Board of Philex Pharmaceutical Industries, effective 23 July 2026. The company said the appointment reflects his experience in medicine, corporate leadership, governance and strategic healthcare development.
According to the announcement, Al Lawati will guide Philex Pharmaceutical Industries as it continues to focus on growth, innovation and healthcare sustainability in Oman and beyond.
Ali Murtadha Al Lawati brings healthcare leadership experience
Philex Pharmaceutical Industries said Al Lawati has built a career spanning medicine, corporate leadership, governance and strategic healthcare development. The company said his experience, combined with his commitment to advancing Oman’s healthcare and pharmaceutical sectors, makes him well placed to lead the organisation during its next phase of development.
The announcement also highlighted his contribution to strengthening the country’s pharmaceutical ecosystem through leadership in healthcare initiatives. His appointment comes as the company continues to support the growth of the pharmaceutical industry while expanding its long-term healthcare objectives.
Focus on Oman’s pharmaceutical sector
Alongside his new position, Al Lawati serves as Executive Director of Mazoon Pharmacy LLC. Philex Pharmaceutical Industries described him as a key contributor to national healthcare initiatives, including the Medical Manufacturing Pillar of Oman Vision 2040.
According to the company, his work has helped support the development of local pharmaceutical manufacturing capabilities while contributing to the wider healthcare ecosystem across the Sultanate. These efforts align with the company’s commitment to strengthening domestic pharmaceutical production and supporting healthcare sustainability.
Supporting the company’s leadership agenda
Philex Pharmaceutical Industries said it looks forward to working under Al Lawati’s leadership as Chairman of the Board. The company stated that it expects his guidance to support its mission of delivering high quality pharmaceutical products, encouraging innovation and contributing to healthcare sustainability in Oman and beyond.
The appointment places experienced leadership at the board level as Philex Pharmaceutical Industries continues to strengthen its position in Oman’s pharmaceutical sector. Al Lawati will use his experience in healthcare, governance and corporate leadership to advance the company’s long-term objectives and strengthen its commitment to innovation and sustainable healthcare development.
